

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell size (GO:0045792) | 6.43093216 |
| 2 | plasma membrane repair (GO:0001778) | 5.28184338 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.08108170 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.08108170 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.03894819 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.03894819 |
| 7 | negative regulation of protein localization to cell surface (GO:2000009) | 4.96441329 |
| 8 | positive regulation of myotube differentiation (GO:0010831) | 4.85307293 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.82667741 |
| 10 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.49054379 |
| 11 | negative regulation of muscle hypertrophy (GO:0014741) | 4.39718576 |
| 12 | lysine metabolic process (GO:0006553) | 4.36049287 |
| 13 | lysine catabolic process (GO:0006554) | 4.36049287 |
| 14 | membrane raft organization (GO:0031579) | 4.33738180 |
| 15 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.27508782 |
| 16 | negative regulation of heart growth (GO:0061117) | 4.27508782 |
| 17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.18113880 |
| 18 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 4.17669986 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.13865561 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.12781534 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.11850575 |
| 22 | valine metabolic process (GO:0006573) | 4.11303698 |
| 23 | regulation of sarcomere organization (GO:0060297) | 4.01504711 |
| 24 | positive regulation of extracellular matrix organization (GO:1903055) | 4.00539332 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 3.97677837 |
| 26 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.95435946 |
| 27 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.89619340 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.87826656 |
| 29 | protein carboxylation (GO:0018214) | 3.87826656 |
| 30 | ethanol oxidation (GO:0006069) | 3.83440905 |
| 31 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.80136842 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 3.76644629 |
| 33 | cysteine metabolic process (GO:0006534) | 3.72998700 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 3.71204394 |
| 35 | regulation of p38MAPK cascade (GO:1900744) | 3.70686912 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 3.70651426 |
| 37 | heart trabecula formation (GO:0060347) | 3.59617080 |
| 38 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.59429986 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.58943476 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.54324086 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.54324086 |
| 42 | Golgi transport vesicle coating (GO:0048200) | 3.51571307 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.51571307 |
| 44 | bile acid biosynthetic process (GO:0006699) | 3.51201560 |
| 45 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51067420 |
| 46 | regulation of cholesterol homeostasis (GO:2000188) | 3.49069772 |
| 47 | kynurenine metabolic process (GO:0070189) | 3.46236333 |
| 48 | negative regulation of organelle assembly (GO:1902116) | 3.44836079 |
| 49 | glycine metabolic process (GO:0006544) | 3.40430923 |
| 50 | urea cycle (GO:0000050) | 3.38658517 |
| 51 | urea metabolic process (GO:0019627) | 3.38658517 |
| 52 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.38070464 |
| 53 | regulation of protein activation cascade (GO:2000257) | 3.34302958 |
| 54 | regulation of fibrinolysis (GO:0051917) | 3.30648730 |
| 55 | modulation by virus of host morphology or physiology (GO:0019048) | 3.24238620 |
| 56 | tricarboxylic acid metabolic process (GO:0072350) | 3.23389620 |
| 57 | fatty acid oxidation (GO:0019395) | 3.19913008 |
| 58 | complement activation, alternative pathway (GO:0006957) | 3.19382850 |
| 59 | regulation of complement activation (GO:0030449) | 3.17546928 |
| 60 | serine family amino acid catabolic process (GO:0009071) | 3.16580840 |
| 61 | basement membrane organization (GO:0071711) | 3.15926636 |
| 62 | negative regulation of striated muscle cell differentiation (GO:0051154) | 3.13550241 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.12752328 |
| 64 | stress fiber assembly (GO:0043149) | 3.11567973 |
| 65 | lipid oxidation (GO:0034440) | 3.09760821 |
| 66 | 4-hydroxyproline metabolic process (GO:0019471) | 3.09454185 |
| 67 | tryptophan catabolic process (GO:0006569) | 3.07710333 |
| 68 | indole-containing compound catabolic process (GO:0042436) | 3.07710333 |
| 69 | indolalkylamine catabolic process (GO:0046218) | 3.07710333 |
| 70 | adherens junction assembly (GO:0034333) | 3.06348801 |
| 71 | regulation of extracellular matrix organization (GO:1903053) | 3.06290888 |
| 72 | glucose catabolic process (GO:0006007) | 3.06212815 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 3.05638611 |
| 74 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.05593518 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 3.05034417 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04832539 |
| 77 | cardiac myofibril assembly (GO:0055003) | 3.04510620 |
| 78 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.04327492 |
| 79 | homocysteine metabolic process (GO:0050667) | 3.03920801 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02774176 |
| 81 | fatty acid beta-oxidation (GO:0006635) | 3.01520010 |
| 82 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.98981508 |
| 83 | regulation of extracellular matrix disassembly (GO:0010715) | 2.98054992 |
| 84 | pinocytosis (GO:0006907) | 2.97307208 |
| 85 | barbed-end actin filament capping (GO:0051016) | 2.96070657 |
| 86 | cell-substrate adherens junction assembly (GO:0007045) | 2.95576457 |
| 87 | focal adhesion assembly (GO:0048041) | 2.95576457 |
| 88 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.92603625 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 2.91394652 |
| 90 | ribosomal small subunit assembly (GO:0000028) | 2.91373929 |
| 91 | oxaloacetate metabolic process (GO:0006107) | 2.90921852 |
| 92 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.90781960 |
| 93 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.89645931 |
| 94 | bile acid metabolic process (GO:0008206) | 2.89494916 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 2.89401840 |
| 96 | negative regulation of sterol transport (GO:0032372) | 2.89401840 |
| 97 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.89315618 |
| 98 | muscle cell cellular homeostasis (GO:0046716) | 2.87924131 |
| 99 | proline biosynthetic process (GO:0006561) | 2.87632284 |
| 100 | regulation of triglyceride catabolic process (GO:0010896) | 2.86444538 |
| 101 | aromatic amino acid family metabolic process (GO:0009072) | 2.86078965 |
| 102 | COPII vesicle coating (GO:0048208) | 2.85747961 |
| 103 | cellular ketone body metabolic process (GO:0046950) | 2.85707748 |
| 104 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.85195339 |
| 105 | alpha-amino acid catabolic process (GO:1901606) | 2.85011703 |
| 106 | tyrosine metabolic process (GO:0006570) | 2.83528193 |
| 107 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.82353490 |
| 108 | negative regulation of fatty acid transport (GO:2000192) | 2.80822658 |
| 109 | striated muscle atrophy (GO:0014891) | 2.79992586 |
| 110 | maternal placenta development (GO:0001893) | 2.79543519 |
| 111 | myoblast fusion (GO:0007520) | 2.79145323 |
| 112 | carnitine metabolic process (GO:0009437) | 2.78997920 |
| 113 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77683944 |
| 114 | negative regulation of monooxygenase activity (GO:0032769) | 2.77305556 |
| 115 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.76908061 |
| 116 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76171440 |
| 117 | reverse cholesterol transport (GO:0043691) | 2.76045225 |
| 118 | protein localization to endosome (GO:0036010) | 2.75930688 |
| 119 | phospholipid efflux (GO:0033700) | 2.74687573 |
| 120 | semaphorin-plexin signaling pathway (GO:0071526) | 2.74182079 |
| 121 | low-density lipoprotein particle clearance (GO:0034383) | 2.73945093 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.73750133 |
| 123 | pentose-phosphate shunt (GO:0006098) | 2.72739893 |
| 124 | plasma lipoprotein particle clearance (GO:0034381) | 2.72505498 |
| 125 | triglyceride homeostasis (GO:0070328) | 2.72085302 |
| 126 | acylglycerol homeostasis (GO:0055090) | 2.72085302 |
| 127 | protein-lipid complex assembly (GO:0065005) | 2.71102025 |
| 128 | cellular amino acid catabolic process (GO:0009063) | 2.69994659 |
| 129 | plasma lipoprotein particle assembly (GO:0034377) | 2.69502265 |
| 130 | trabecula formation (GO:0060343) | 2.68466893 |
| 131 | apoptotic process involved in morphogenesis (GO:0060561) | 2.67837080 |
| 132 | branched-chain amino acid metabolic process (GO:0009081) | 2.66514796 |
| 133 | response to laminar fluid shear stress (GO:0034616) | 2.66406497 |
| 134 | fatty acid transmembrane transport (GO:1902001) | 2.66399820 |
| 135 | regulation of protein localization to cell surface (GO:2000008) | 2.65715265 |
| 136 | cellular modified amino acid catabolic process (GO:0042219) | 2.65553926 |
| 137 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.64653701 |
| 138 | one-carbon metabolic process (GO:0006730) | 2.64530567 |
| 139 | epithelial cell-cell adhesion (GO:0090136) | 2.62693829 |
| 140 | fatty acid catabolic process (GO:0009062) | 2.61973499 |
| 141 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.61584167 |
| 142 | ethanol metabolic process (GO:0006067) | 2.61264146 |
| 143 | regulation of early endosome to late endosome transport (GO:2000641) | 2.61225497 |
| 144 | cell-substrate junction assembly (GO:0007044) | 2.61144610 |
| 145 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.60295399 |
| 146 | convergent extension (GO:0060026) | 2.59323955 |
| 147 | protein retention in ER lumen (GO:0006621) | 2.58608290 |
| 148 | monocarboxylic acid catabolic process (GO:0072329) | 2.58168386 |
| 149 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.57748009 |
| 150 | skin morphogenesis (GO:0043589) | 2.56912709 |
| 151 | serine family amino acid biosynthetic process (GO:0009070) | 2.56440041 |
| 152 | cochlea morphogenesis (GO:0090103) | 2.56175875 |
| 153 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.55413301 |
| 154 | atrioventricular valve morphogenesis (GO:0003181) | 2.54638694 |
| 155 | modulation by virus of host process (GO:0019054) | 2.54253812 |
| 156 | acetyl-CoA metabolic process (GO:0006084) | 2.54073320 |
| 157 | carnitine shuttle (GO:0006853) | 2.52776094 |
| 158 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52114367 |
| 159 | cholesterol homeostasis (GO:0042632) | 2.51856206 |
| 160 | primary alcohol catabolic process (GO:0034310) | 2.51727653 |
| 161 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.51698978 |
| 162 | NADPH regeneration (GO:0006740) | 2.50223872 |
| 163 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.49546284 |
| 164 | carboxylic acid catabolic process (GO:0046395) | 2.49487037 |
| 165 | organic acid catabolic process (GO:0016054) | 2.49487037 |
| 166 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.48051713 |
| 167 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.43753825 |
| 168 | mannose metabolic process (GO:0006013) | 2.42651054 |
| 169 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.41428727 |
| 170 | NADH metabolic process (GO:0006734) | 2.40141482 |
| 171 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.37837546 |
| 172 | regulation of establishment of planar polarity (GO:0090175) | 2.36031740 |
| 173 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.34979359 |
| 174 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.34208310 |
| 175 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.34203268 |
| 176 | regulation of ARF protein signal transduction (GO:0032012) | 2.33449706 |
| 177 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.32945251 |
| 178 | cell-cell junction maintenance (GO:0045217) | 2.31140871 |
| 179 | negative regulation of viral release from host cell (GO:1902187) | 2.30578921 |
| 180 | positive regulation of adherens junction organization (GO:1903393) | 2.30311817 |
| 181 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.27903484 |
| 182 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.27224911 |
| 183 | muscle atrophy (GO:0014889) | 2.27024167 |
| 184 | apoptotic cell clearance (GO:0043277) | 2.26427455 |
| 185 | membrane assembly (GO:0071709) | 2.25290376 |
| 186 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.25130718 |
| 187 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.24940079 |
| 188 | glucose 6-phosphate metabolic process (GO:0051156) | 2.24047372 |
| 189 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.23347198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.74584733 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.28109186 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.85971269 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81061289 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11725790 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.04425641 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.63241816 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.58018307 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.55664243 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.48741661 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.15495049 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10245985 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09997942 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99971704 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96604063 |
| 16 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.91367414 |
| 17 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.91367414 |
| 18 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.91367414 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88019723 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86770376 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85995619 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82555797 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.78531186 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78216863 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76491327 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75530729 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71932718 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69476355 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67726329 |
| 30 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.67529739 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66600560 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65737249 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63120306 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.62434444 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.60819883 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56735689 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54978540 |
| 38 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.54128372 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51083745 |
| 40 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.50484753 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.49411243 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47268376 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42982742 |
| 44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41055368 |
| 45 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38834267 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.38518514 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37995397 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37882635 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37537140 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36443953 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35307897 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34228540 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33469986 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31662910 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30824199 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30371763 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29916282 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29206692 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29120377 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28891690 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26885164 |
| 62 | * P68_20966046_ChIP-Seq_HELA_Human | 1.25778757 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25433281 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24945025 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24715554 |
| 66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23619059 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23163471 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22019497 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21863463 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21318719 |
| 71 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20679679 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20536193 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20477542 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19859922 |
| 75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18909783 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18029385 |
| 77 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16980652 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16908266 |
| 79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16670586 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16195894 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15327034 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13392879 |
| 83 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12619811 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12499567 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12203227 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11600845 |
| 87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11600845 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10942051 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10441573 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10300861 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08682549 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08009200 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07313520 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07184000 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06664870 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06434397 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05931933 |
| 98 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.05335529 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04263844 |
| 100 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03559672 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03083273 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03046270 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02628708 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02381011 |
| 105 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02218203 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02114875 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01279099 |
| 108 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01206020 |
| 109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00870266 |
| 110 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00727038 |
| 111 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.00411406 |
| 112 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00180748 |
| 113 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99861815 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99803720 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98395206 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98365902 |
| 117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97684182 |
| 118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96838711 |
| 119 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96801580 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95978349 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 0.95834289 |
| 122 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95487382 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94409491 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94321613 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94008103 |
| 126 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92703712 |
| 127 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.92413119 |
| 128 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92049531 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91778497 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91476424 |
| 131 | MAF_26560356_Chip-Seq_TH2_Human | 0.91385128 |
| 132 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91074948 |
| 133 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90675547 |
| 134 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90297514 |
| 135 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.89795769 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89362711 |
| 137 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89285291 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88677363 |
| 139 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88384829 |
| 140 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87678678 |
| 141 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87256237 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86505237 |
| 143 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85994255 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85719200 |
| 145 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85315699 |
| 146 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.84568301 |
| 147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84199563 |
| 148 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83973718 |
| 149 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83140167 |
| 150 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.82266569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.75637538 |
| 2 | MP0005360_urolithiasis | 3.86237849 |
| 3 | MP0005365_abnormal_bile_salt | 3.66015906 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.65124524 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.28569554 |
| 6 | MP0000751_myopathy | 3.22170701 |
| 7 | MP0004272_abnormal_basement_membrane | 2.91644404 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.66776152 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.57741852 |
| 10 | MP0003878_abnormal_ear_physiology | 2.57741852 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.45266973 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.36320215 |
| 13 | MP0009840_abnormal_foam_cell | 2.34325065 |
| 14 | MP0010030_abnormal_orbit_morphology | 2.32093358 |
| 15 | MP0003252_abnormal_bile_duct | 2.28048774 |
| 16 | MP0004858_abnormal_nervous_system | 2.27864438 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.22360099 |
| 18 | MP0005451_abnormal_body_composition | 2.19937467 |
| 19 | MP0001958_emphysema | 2.16639329 |
| 20 | MP0000749_muscle_degeneration | 2.12010335 |
| 21 | MP0006054_spinal_hemorrhage | 2.03423927 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.99801235 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.97464841 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 1.80617638 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.75763455 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.75650383 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.74062382 |
| 28 | MP0003091_abnormal_cell_migration | 1.72657174 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.70725296 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.70311224 |
| 31 | MP0008260_abnormal_autophagy | 1.67661567 |
| 32 | MP0000609_abnormal_liver_physiology | 1.66642802 |
| 33 | MP0002249_abnormal_larynx_morphology | 1.63361095 |
| 34 | MP0005409_darkened_coat_color | 1.58017699 |
| 35 | MP0005083_abnormal_biliary_tract | 1.55693207 |
| 36 | MP0003279_aneurysm | 1.54223524 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.52669110 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.50449956 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.49786521 |
| 40 | MP0000858_altered_metastatic_potential | 1.48304320 |
| 41 | MP0005332_abnormal_amino_acid | 1.45972657 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.44901512 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.43639107 |
| 44 | MP0003828_pulmonary_edema | 1.42832282 |
| 45 | MP0003195_calcinosis | 1.42776035 |
| 46 | MP0003303_peritoneal_inflammation | 1.36716633 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.35708110 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.30105472 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 1.29690744 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.27097664 |
| 51 | MP0005330_cardiomyopathy | 1.26932277 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.26512317 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.24895970 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.24529402 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.23407445 |
| 56 | MP0005670_abnormal_white_adipose | 1.21877763 |
| 57 | MP0000598_abnormal_liver_morphology | 1.21328239 |
| 58 | MP0001756_abnormal_urination | 1.20053463 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.18395983 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.17040584 |
| 61 | MP0004233_abnormal_muscle_weight | 1.16172079 |
| 62 | MP0004087_abnormal_muscle_fiber | 1.13828017 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.13681073 |
| 64 | MP0005503_abnormal_tendon_morphology | 1.11943068 |
| 65 | MP0003868_abnormal_feces_composition | 1.10192389 |
| 66 | MP0005023_abnormal_wound_healing | 1.07425572 |
| 67 | MP0003115_abnormal_respiratory_system | 1.06360698 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.04457650 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.01276077 |
| 70 | MP0002254_reproductive_system_inflammat | 1.00756997 |
| 71 | MP0003186_abnormal_redox_activity | 0.96973388 |
| 72 | MP0005501_abnormal_skin_physiology | 0.96883616 |
| 73 | MP0002796_impaired_skin_barrier | 0.95978174 |
| 74 | MP0000537_abnormal_urethra_morphology | 0.95682746 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.93927452 |
| 76 | MP0000685_abnormal_immune_system | 0.92819826 |
| 77 | MP0001542_abnormal_bone_strength | 0.92507857 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 0.92260534 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.91980888 |
| 80 | MP0005508_abnormal_skeleton_morphology | 0.90629694 |
| 81 | MP0002108_abnormal_muscle_morphology | 0.89932342 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89838214 |
| 83 | MP0000747_muscle_weakness | 0.89571303 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.89396785 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.89396785 |
| 86 | MP0005408_hypopigmentation | 0.89072702 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.88773575 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.87714695 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.87111008 |
| 90 | MP0004883_abnormal_blood_vessel | 0.86941405 |
| 91 | MP0001915_intracranial_hemorrhage | 0.85993427 |
| 92 | MP0009278_abnormal_bone_marrow | 0.85919846 |
| 93 | MP0001849_ear_inflammation | 0.85139602 |
| 94 | MP0009053_abnormal_anal_canal | 0.85015116 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.84720088 |
| 96 | MP0004130_abnormal_muscle_cell | 0.83286083 |
| 97 | MP0009697_abnormal_copulation | 0.82748835 |
| 98 | MP0006138_congestive_heart_failure | 0.82357819 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.82274169 |
| 100 | MP0004019_abnormal_vitamin_homeostasis | 0.82104395 |
| 101 | MP0004885_abnormal_endolymph | 0.81037441 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.80326458 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.80287416 |
| 104 | MP0001764_abnormal_homeostasis | 0.78268466 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.77859529 |
| 106 | MP0000462_abnormal_digestive_system | 0.77208158 |
| 107 | MP0009763_increased_sensitivity_to | 0.76939496 |
| 108 | MP0005390_skeleton_phenotype | 0.76041865 |
| 109 | MP0001614_abnormal_blood_vessel | 0.75558506 |
| 110 | MP0000490_abnormal_crypts_of | 0.75478695 |
| 111 | MP0009672_abnormal_birth_weight | 0.75317505 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.74507935 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.74091454 |
| 114 | MP0002933_joint_inflammation | 0.74017871 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.73798666 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.73677270 |
| 117 | MP0002106_abnormal_muscle_physiology | 0.72673670 |
| 118 | MP0003385_abnormal_body_wall | 0.72619567 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.72229427 |
| 120 | MP0001873_stomach_inflammation | 0.72150514 |
| 121 | MP0002092_abnormal_eye_morphology | 0.72001758 |
| 122 | MP0008469_abnormal_protein_level | 0.71735356 |
| 123 | MP0005275_abnormal_skin_tensile | 0.70173425 |
| 124 | MP0002128_abnormal_blood_circulation | 0.70154923 |
| 125 | MP0002086_abnormal_extraembryonic_tissu | 0.69648494 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.69106472 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.69060414 |
| 128 | MP0002113_abnormal_skeleton_development | 0.68986085 |
| 129 | MP0003724_increased_susceptibility_to | 0.68755413 |
| 130 | MP0001270_distended_abdomen | 0.68617438 |
| 131 | MP0002088_abnormal_embryonic_growth/wei | 0.68207956 |
| 132 | MP0002269_muscular_atrophy | 0.68198658 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.68005002 |
| 134 | MP0002166_altered_tumor_susceptibility | 0.67757135 |
| 135 | MP0002060_abnormal_skin_morphology | 0.67439306 |
| 136 | MP0002932_abnormal_joint_morphology | 0.66773188 |
| 137 | MP0003984_embryonic_growth_retardation | 0.66570819 |
| 138 | MP0003011_delayed_dark_adaptation | 0.65585654 |
| 139 | MP0005369_muscle_phenotype | 0.65406591 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.65348375 |
| 141 | MP0003795_abnormal_bone_structure | 0.65281446 |
| 142 | MP0001697_abnormal_embryo_size | 0.64725160 |
| 143 | MP0001879_abnormal_lymphatic_vessel | 0.64595954 |
| 144 | MP0004084_abnormal_cardiac_muscle | 0.64379401 |
| 145 | MP0010155_abnormal_intestine_physiology | 0.64154764 |
| 146 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63883301 |
| 147 | MP0003436_decreased_susceptibility_to | 0.63496094 |
| 148 | MP0004782_abnormal_surfactant_physiolog | 0.63399463 |
| 149 | MP0000681_abnormal_thyroid_gland | 0.63293344 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.62872179 |
| 151 | MP0000733_abnormal_muscle_development | 0.62269805 |
| 152 | MP0002970_abnormal_white_adipose | 0.62230126 |
| 153 | MP0001661_extended_life_span | 0.61823406 |
| 154 | MP0003329_amyloid_beta_deposits | 0.61759926 |
| 155 | MP0002078_abnormal_glucose_homeostasis | 0.61536483 |
| 156 | MP0003942_abnormal_urinary_system | 0.61405812 |
| 157 | MP0009115_abnormal_fat_cell | 0.61286861 |
| 158 | MP0002925_abnormal_cardiovascular_devel | 0.61246596 |
| 159 | MP0001216_abnormal_epidermal_layer | 0.60794884 |
| 160 | MP0005375_adipose_tissue_phenotype | 0.60136111 |
| 161 | MP0001730_embryonic_growth_arrest | 0.59696855 |
| 162 | MP0000249_abnormal_blood_vessel | 0.59485487 |
| 163 | MP0005334_abnormal_fat_pad | 0.58983205 |
| 164 | MP0009642_abnormal_blood_homeostasis | 0.58333252 |
| 165 | MP0002837_dystrophic_cardiac_calcinosis | 0.57936445 |
| 166 | MP0002135_abnormal_kidney_morphology | 0.56665699 |
| 167 | MP0002971_abnormal_brown_adipose | 0.56654921 |
| 168 | MP0004947_skin_inflammation | 0.56250723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.11054166 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.98741978 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.85293372 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.45194631 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.31427789 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.22750859 |
| 7 | Arterial tortuosity (HP:0005116) | 4.19362312 |
| 8 | Xanthomatosis (HP:0000991) | 4.05157512 |
| 9 | Vascular tortuosity (HP:0004948) | 4.02484993 |
| 10 | Distal lower limb muscle weakness (HP:0009053) | 3.78841682 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.73575619 |
| 12 | Subaortic stenosis (HP:0001682) | 3.70392760 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.70392760 |
| 14 | Turricephaly (HP:0000262) | 3.60173959 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 3.56355383 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.54427251 |
| 17 | Ketosis (HP:0001946) | 3.50581768 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.32528482 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.30596627 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.16068254 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.07947648 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.07063403 |
| 23 | Ketoacidosis (HP:0001993) | 3.01682628 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.99147933 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.96867214 |
| 26 | Muscle stiffness (HP:0003552) | 2.94429665 |
| 27 | Complement deficiency (HP:0004431) | 2.93923248 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 2.92757058 |
| 29 | Hyperammonemia (HP:0001987) | 2.91608123 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.91502519 |
| 31 | Aortic dissection (HP:0002647) | 2.90939009 |
| 32 | Vertebral compression fractures (HP:0002953) | 2.85797968 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 2.83813723 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.73365217 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.72242844 |
| 36 | Joint hemorrhage (HP:0005261) | 2.71609268 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.67808258 |
| 38 | Ulnar bowing (HP:0003031) | 2.67045239 |
| 39 | Spastic diplegia (HP:0001264) | 2.66762620 |
| 40 | Hypercholesterolemia (HP:0003124) | 2.65936293 |
| 41 | Myopathic facies (HP:0002058) | 2.60977937 |
| 42 | Sudden death (HP:0001699) | 2.46915434 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 2.46811783 |
| 44 | Esophageal varix (HP:0002040) | 2.46713210 |
| 45 | Broad metatarsal (HP:0001783) | 2.46388805 |
| 46 | Late onset (HP:0003584) | 2.45321542 |
| 47 | Spondylolisthesis (HP:0003302) | 2.45262378 |
| 48 | Polycythemia (HP:0001901) | 2.44626104 |
| 49 | Blue sclerae (HP:0000592) | 2.42638897 |
| 50 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.42199129 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.39812296 |
| 52 | Hyperacusis (HP:0010780) | 2.39147904 |
| 53 | Hyperbilirubinemia (HP:0002904) | 2.38537688 |
| 54 | Mitral regurgitation (HP:0001653) | 2.38021920 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37865920 |
| 56 | Hyperglycinuria (HP:0003108) | 2.36581304 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36426814 |
| 58 | Fat malabsorption (HP:0002630) | 2.34211384 |
| 59 | Spinal rigidity (HP:0003306) | 2.27755238 |
| 60 | Thin bony cortex (HP:0002753) | 2.27137575 |
| 61 | Thrombocytosis (HP:0001894) | 2.23757672 |
| 62 | Abnormal platelet volume (HP:0011876) | 2.23627488 |
| 63 | Abnormal platelet function (HP:0011869) | 2.22323056 |
| 64 | Impaired platelet aggregation (HP:0003540) | 2.22323056 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.22048758 |
| 66 | Myocardial infarction (HP:0001658) | 2.22021262 |
| 67 | Gingival bleeding (HP:0000225) | 2.20628675 |
| 68 | Increased connective tissue (HP:0009025) | 2.19797600 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19761799 |
| 70 | Abnormality of the nasal mucosa (HP:0000433) | 2.19053822 |
| 71 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.18839847 |
| 72 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.18839847 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.18205639 |
| 74 | Hypoglycemic seizures (HP:0002173) | 2.17789312 |
| 75 | Aortic regurgitation (HP:0001659) | 2.15800131 |
| 76 | Dilatation of the ascending aorta (HP:0005111) | 2.13113021 |
| 77 | Biconcave vertebral bodies (HP:0004586) | 2.11813992 |
| 78 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11765542 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.11722296 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.11471805 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.11005842 |
| 82 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11005842 |
| 83 | Epidermoid cyst (HP:0200040) | 2.10916411 |
| 84 | Myoglobinuria (HP:0002913) | 2.10541642 |
| 85 | Peritonitis (HP:0002586) | 2.10298296 |
| 86 | Abnormality of complement system (HP:0005339) | 2.09607264 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09338076 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.08543134 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08232065 |
| 90 | Bladder diverticulum (HP:0000015) | 2.08196152 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.07085192 |
| 92 | Neck muscle weakness (HP:0000467) | 2.06936099 |
| 93 | Type 1 muscle fiber predominance (HP:0003803) | 2.06578273 |
| 94 | Aneurysm (HP:0002617) | 2.05479511 |
| 95 | Joint laxity (HP:0001388) | 2.05407446 |
| 96 | Broad face (HP:0000283) | 2.04659801 |
| 97 | Acanthocytosis (HP:0001927) | 2.04235058 |
| 98 | Back pain (HP:0003418) | 2.03926831 |
| 99 | Ankle contracture (HP:0006466) | 2.03803155 |
| 100 | Abnormality of methionine metabolism (HP:0010901) | 2.03644371 |
| 101 | Increased serum ferritin (HP:0003281) | 2.03578877 |
| 102 | Flat acetabular roof (HP:0003180) | 2.03360978 |
| 103 | Asymmetry of the thorax (HP:0001555) | 2.00087879 |
| 104 | Shallow orbits (HP:0000586) | 1.99179263 |
| 105 | Disproportionate tall stature (HP:0001519) | 1.98723834 |
| 106 | Mitral valve prolapse (HP:0001634) | 1.98377808 |
| 107 | Hyperglycinemia (HP:0002154) | 1.97557693 |
| 108 | Hypoplasia of the thymus (HP:0000778) | 1.96709027 |
| 109 | Cerebral aneurysm (HP:0004944) | 1.95898935 |
| 110 | Fragile skin (HP:0001030) | 1.95880206 |
| 111 | Achilles tendon contracture (HP:0001771) | 1.94183756 |
| 112 | Abnormality of the calf musculature (HP:0001430) | 1.93675196 |
| 113 | Myotonia (HP:0002486) | 1.92910646 |
| 114 | Radial bowing (HP:0002986) | 1.92666433 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92185796 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 1.92185796 |
| 117 | Dysostosis multiplex (HP:0000943) | 1.91041853 |
| 118 | Soft skin (HP:0000977) | 1.90915664 |
| 119 | Cervical subluxation (HP:0003308) | 1.90593073 |
| 120 | Delayed CNS myelination (HP:0002188) | 1.90136296 |
| 121 | Wormian bones (HP:0002645) | 1.88722594 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 1.88706376 |
| 123 | Epistaxis (HP:0000421) | 1.88705321 |
| 124 | Thrombophlebitis (HP:0004418) | 1.87525382 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.87208206 |
| 126 | Short nail (HP:0001799) | 1.87114676 |
| 127 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86918295 |
| 128 | Abnormality of the acetabulum (HP:0003170) | 1.86658450 |
| 129 | Bowed forearm bones (HP:0003956) | 1.86563813 |
| 130 | Bowing of the arm (HP:0006488) | 1.86563813 |
| 131 | Metatarsus adductus (HP:0001840) | 1.84795668 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.84779169 |
| 133 | Long toe (HP:0010511) | 1.84539061 |
| 134 | Beaking of vertebral bodies (HP:0004568) | 1.83485992 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83127378 |
| 136 | Menorrhagia (HP:0000132) | 1.83058150 |
| 137 | Metabolic acidosis (HP:0001942) | 1.82671186 |
| 138 | Mitral stenosis (HP:0001718) | 1.81917670 |
| 139 | Genu recurvatum (HP:0002816) | 1.81635071 |
| 140 | Upper limb amyotrophy (HP:0009129) | 1.78507782 |
| 141 | Distal upper limb amyotrophy (HP:0007149) | 1.78507782 |
| 142 | Purpura (HP:0000979) | 1.78205743 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78110506 |
| 144 | Ectopia lentis (HP:0001083) | 1.77854606 |
| 145 | Gowers sign (HP:0003391) | 1.75904580 |
| 146 | Aortic aneurysm (HP:0004942) | 1.75409463 |
| 147 | Skin nodule (HP:0200036) | 1.75355855 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.75318135 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75318135 |
| 150 | Steatorrhea (HP:0002570) | 1.75100019 |
| 151 | Thoracic kyphosis (HP:0002942) | 1.75018254 |
| 152 | Abnormality of the thoracic spine (HP:0100711) | 1.74060005 |
| 153 | Abnormality of the 4th metacarpal (HP:0010012) | 1.74019937 |
| 154 | Atrophic scars (HP:0001075) | 1.73772620 |
| 155 | Gout (HP:0001997) | 1.72727967 |
| 156 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70886437 |
| 157 | Hepatosplenomegaly (HP:0001433) | 1.70773309 |
| 158 | Axonal loss (HP:0003447) | 1.70392858 |
| 159 | Hyperextensible skin (HP:0000974) | 1.70213667 |
| 160 | Increased cerebral lipofuscin (HP:0011813) | 1.69964987 |
| 161 | Premature rupture of membranes (HP:0001788) | 1.69943129 |
| 162 | Hyperglycemia (HP:0003074) | 1.69732004 |
| 163 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.68665878 |
| 164 | Abnormality of carpal bone ossification (HP:0006257) | 1.68660657 |
| 165 | Enlarged penis (HP:0000040) | 1.68619074 |
| 166 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67911916 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67911916 |
| 168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67911916 |
| 169 | Cupped ribs (HP:0000887) | 1.65853754 |
| 170 | Lymphangioma (HP:0100764) | 1.65517035 |
| 171 | Abnormal ossification of hand bones (HP:0005921) | 1.65071359 |
| 172 | Spontaneous abortion (HP:0005268) | 1.64780029 |
| 173 | Joint stiffness (HP:0001387) | 1.64701776 |
| 174 | Easy fatigability (HP:0003388) | 1.64675236 |
| 175 | Systemic lupus erythematosus (HP:0002725) | 1.64376790 |
| 176 | Hyporeflexia of lower limbs (HP:0002600) | 1.62885605 |
| 177 | Renal duplication (HP:0000075) | 1.61957436 |
| 178 | Long palpebral fissure (HP:0000637) | 1.60928002 |
| 179 | Round ear (HP:0100830) | 1.59865620 |
| 180 | Ulnar deviation of the wrist (HP:0003049) | 1.59717882 |
| 181 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.57629118 |
| 182 | Abnormality of dentin (HP:0010299) | 1.57521845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.23461773 |
| 2 | SMG1 | 3.37791833 |
| 3 | TRIB3 | 3.28653876 |
| 4 | BCKDK | 3.27534526 |
| 5 | PKN2 | 3.12464700 |
| 6 | EEF2K | 3.02864029 |
| 7 | PRPF4B | 2.67120096 |
| 8 | TGFBR1 | 2.59780744 |
| 9 | FLT3 | 2.56019338 |
| 10 | MAP4K1 | 2.53256916 |
| 11 | FGFR4 | 2.45715528 |
| 12 | SIK1 | 2.34712483 |
| 13 | TGFBR2 | 2.27074725 |
| 14 | MAP3K10 | 2.19010469 |
| 15 | MAPKAPK5 | 1.93205632 |
| 16 | PTK6 | 1.89724952 |
| 17 | CDK8 | 1.89303354 |
| 18 | IRAK3 | 1.86838089 |
| 19 | EPHA2 | 1.83812234 |
| 20 | PDGFRA | 1.81711216 |
| 21 | TIE1 | 1.78871616 |
| 22 | RIPK1 | 1.76230819 |
| 23 | TESK1 | 1.75660799 |
| 24 | LRRK2 | 1.74442591 |
| 25 | JAK3 | 1.72668670 |
| 26 | LATS1 | 1.66368380 |
| 27 | TAOK3 | 1.64940734 |
| 28 | TTN | 1.61593195 |
| 29 | STK10 | 1.50090728 |
| 30 | MAP3K11 | 1.49170058 |
| 31 | TESK2 | 1.42555798 |
| 32 | TAOK2 | 1.42404075 |
| 33 | DYRK3 | 1.42380012 |
| 34 | DDR2 | 1.35650993 |
| 35 | MUSK | 1.35214355 |
| 36 | MARK2 | 1.32624648 |
| 37 | RPS6KB2 | 1.29868215 |
| 38 | PRKD2 | 1.29740466 |
| 39 | KDR | 1.26511172 |
| 40 | ACVR1B | 1.25628796 |
| 41 | CDK4 | 1.24002936 |
| 42 | LMTK2 | 1.21973238 |
| 43 | PASK | 1.21254598 |
| 44 | CDK6 | 1.18072523 |
| 45 | EPHB1 | 1.17424623 |
| 46 | MAP2K3 | 1.17259001 |
| 47 | PAK4 | 1.16246256 |
| 48 | HIPK2 | 1.14868570 |
| 49 | TYRO3 | 1.14644708 |
| 50 | PRKD3 | 1.12698466 |
| 51 | ZAP70 | 1.12502446 |
| 52 | RPS6KA4 | 1.10660251 |
| 53 | ARAF | 1.10309763 |
| 54 | BTK | 1.10255418 |
| 55 | PTK2 | 1.10008409 |
| 56 | INSRR | 1.05879629 |
| 57 | MOS | 1.01943306 |
| 58 | MTOR | 1.00262496 |
| 59 | SCYL2 | 0.99158988 |
| 60 | EPHB2 | 0.98728113 |
| 61 | MAP3K8 | 0.96866623 |
| 62 | CDC42BPA | 0.96281118 |
| 63 | TYK2 | 0.95390626 |
| 64 | PIM2 | 0.95150175 |
| 65 | CAMK1D | 0.92920415 |
| 66 | ICK | 0.90774611 |
| 67 | KIT | 0.85779983 |
| 68 | RPS6KA2 | 0.84283430 |
| 69 | MELK | 0.81687108 |
| 70 | MAPK7 | 0.78810415 |
| 71 | TBK1 | 0.78529258 |
| 72 | KSR2 | 0.77787445 |
| 73 | EPHA3 | 0.77707128 |
| 74 | MAP3K6 | 0.77213886 |
| 75 | PDPK1 | 0.77115109 |
| 76 | STK3 | 0.76917931 |
| 77 | MAPKAPK3 | 0.75969837 |
| 78 | GRK6 | 0.75745706 |
| 79 | NEK2 | 0.74705253 |
| 80 | MAP3K3 | 0.74046403 |
| 81 | CCNB1 | 0.73786331 |
| 82 | CDK12 | 0.72985363 |
| 83 | IRAK2 | 0.72182967 |
| 84 | JAK2 | 0.70724135 |
| 85 | MET | 0.70158868 |
| 86 | MAPK11 | 0.69524040 |
| 87 | BRSK2 | 0.69230825 |
| 88 | WEE1 | 0.68684866 |
| 89 | RPS6KL1 | 0.67697667 |
| 90 | RPS6KC1 | 0.67697667 |
| 91 | NME2 | 0.66919135 |
| 92 | CAMK1G | 0.58362914 |
| 93 | LATS2 | 0.56758221 |
| 94 | NTRK1 | 0.56053805 |
| 95 | FGFR3 | 0.55893102 |
| 96 | PRKG2 | 0.55181923 |
| 97 | PAK2 | 0.54975119 |
| 98 | JAK1 | 0.53707430 |
| 99 | FGFR2 | 0.53615760 |
| 100 | CDK7 | 0.53170579 |
| 101 | MAP3K1 | 0.52548430 |
| 102 | TAOK1 | 0.52248171 |
| 103 | TNK2 | 0.51721982 |
| 104 | MAPK15 | 0.51699628 |
| 105 | CDK9 | 0.50862872 |
| 106 | DMPK | 0.50560416 |
| 107 | DYRK1B | 0.50548880 |
| 108 | PDGFRB | 0.50469349 |
| 109 | ITK | 0.48286326 |
| 110 | BMX | 0.48149756 |
| 111 | CSK | 0.48127795 |
| 112 | MAP2K2 | 0.47542866 |
| 113 | NLK | 0.47067002 |
| 114 | PIK3CG | 0.45228474 |
| 115 | IRAK4 | 0.44950694 |
| 116 | MAPK12 | 0.44287268 |
| 117 | MAPK4 | 0.44121865 |
| 118 | CHUK | 0.42964642 |
| 119 | RPS6KA6 | 0.42609485 |
| 120 | MYLK | 0.42512563 |
| 121 | STK38 | 0.41734164 |
| 122 | FGFR1 | 0.41706560 |
| 123 | CSNK1G1 | 0.40826013 |
| 124 | CDC7 | 0.40335111 |
| 125 | AURKB | 0.40211977 |
| 126 | AKT2 | 0.39469526 |
| 127 | CSF1R | 0.39037468 |
| 128 | ILK | 0.37201929 |
| 129 | PIM1 | 0.36277997 |
| 130 | GSK3A | 0.35449192 |
| 131 | MAP3K7 | 0.35398005 |
| 132 | RET | 0.34312235 |
| 133 | PAK6 | 0.33323690 |
| 134 | ROCK2 | 0.33168991 |
| 135 | NEK1 | 0.32718013 |
| 136 | CSNK1G3 | 0.32676967 |
| 137 | NEK9 | 0.32481983 |
| 138 | BLK | 0.32300400 |
| 139 | MAP3K13 | 0.32156686 |
| 140 | CSNK1A1L | 0.31480367 |
| 141 | MAPKAPK2 | 0.29817926 |
| 142 | STK4 | 0.29164784 |
| 143 | CLK1 | 0.28902837 |
| 144 | MAPK3 | 0.28437682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.38494218 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06400556 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79193694 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77528695 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40750831 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.37780634 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.34364221 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.23606427 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.19037116 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.14939430 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.12400381 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09096509 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04917898 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04682886 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03759863 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03642696 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89156025 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83595637 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80120607 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.76284305 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.75261067 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75093102 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71478273 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70252081 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.67954135 |
| 26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.66730362 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.62933804 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62282681 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59766734 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.59166147 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.52047829 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47913818 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40054079 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39104457 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38248610 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33617708 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30652306 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30400699 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30224263 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.30069150 |
| 41 | Colorectal cancer_Homo sapiens_hsa05210 | 1.28352066 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28222953 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28063453 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28038000 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27315375 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26037456 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 1.25466251 |
| 48 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24783957 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.23383009 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21071848 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19695237 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19280296 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15744816 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13940813 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13765641 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12529224 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09678853 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07688461 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 1.07562417 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05180300 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01257048 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.99906247 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.99530809 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97911932 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97624650 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.97344037 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95404714 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94464275 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94460915 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94372317 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.94037216 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.92089916 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88919131 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.88861830 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88639648 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.87010900 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.86436807 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.86431913 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85858478 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85035867 |
| 81 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83709263 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81893416 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.81726701 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81649742 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80122656 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79575888 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76886856 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74311264 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73079423 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72051287 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68099717 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.67512909 |
| 93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67166691 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66965652 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66575129 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65520585 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.62620158 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60908750 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60420649 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.60354756 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60180435 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59529842 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59338690 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58964831 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58813769 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58790272 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58735617 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58353704 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58102621 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56563775 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56552745 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56196169 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56044089 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55583813 |
| 115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55496931 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55489173 |
| 117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54113042 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54075277 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.53573583 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52546497 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52247224 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51630374 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50110520 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47332038 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46401253 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44062651 |
| 127 | DNA replication_Homo sapiens_hsa03030 | 0.43558174 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42248745 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41434207 |
| 130 | Ribosome_Homo sapiens_hsa03010 | 0.40635356 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38063301 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37948341 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35592158 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35061499 |
| 135 | Base excision repair_Homo sapiens_hsa03410 | 0.33172637 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32806476 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30627526 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30604050 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29977415 |
| 140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29646813 |
| 141 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28217118 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27377378 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26759571 |
| 144 | Cell cycle_Homo sapiens_hsa04110 | 0.26633637 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26362392 |
| 146 | Legionellosis_Homo sapiens_hsa05134 | 0.26101098 |
| 147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25805143 |
| 148 | Bladder cancer_Homo sapiens_hsa05219 | 0.25072695 |
| 149 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24295589 |
| 150 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22952932 |
| 151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22474764 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21573672 |
| 153 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.20520334 |
| 154 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20363818 |
| 155 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20131858 |
| 156 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20016899 |
| 157 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19536684 |

